English
简体中文
Total: £ 56.28
Published Date: 2025-07-03 | Pages: 157 | Tables: 151 | Medical Care
In 2024, the global market size of Healthcare Nanotechnology was estimated to be worth US$ 246930 million and is forecast to reach approximately US$ 464970 million by 2031 with a CAGR of 9.6% during the forecast period 2025-2031.
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
The industry is crowded with producers and fierce competition. The U.S. has the highest share of income by region, at more than 48 percent.The key manufacturers are Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International etc. Top 3 companies occupied about 2% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Healthcare Nanotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare Nanotechnology.
The Healthcare Nanotechnology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Healthcare Nanotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Healthcare Nanotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
Segment by Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Others
Segment by Application
Anticancer
CNS Product
Anti-infective
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Healthcare Nanotechnology in global and regional level.
Chapter 3: Detailed analysis of Healthcare Nanotechnology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Healthcare Nanotechnology revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Healthcare Nanotechnology Product Introduction
1.2 Market by Type
1.2.1 Global Healthcare Nanotechnology Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Nanomedicine
1.2.3 Nano Medical Devices
1.2.4 Nano Diagnosis
1.2.5 Others
1.3 Market by Application
1.3.1 Global Healthcare Nanotechnology Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Healthcare Nanotechnology Market Size Estimates and Forecasts
2.2 Healthcare Nanotechnology Market Size by Region: 2024 Versus 2031
2.2.1 Global Healthcare Nanotechnology Revenue by Region: 2020-2025
2.2.2 Global Healthcare Nanotechnology Revenue Forecast by Region (2026-2031)
2.2.3 Global Healthcare Nanotechnology Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Healthcare Nanotechnology Revenue by Type (2020-2031)
3.1.2 Global Healthcare Nanotechnology Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Healthcare Nanotechnology Revenue by Application (2020-2031)
3.2.2 Global Healthcare Nanotechnology Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Nanomedicine of Healthcare Nanotechnology Revenue Market Share by Application
3.3.2 Nano Medical Devices of Healthcare Nanotechnology Revenue Market Share by Application
3.3.3 Nano Diagnosis of Healthcare Nanotechnology Revenue Market Share by Application
3.3.4 Others of Healthcare Nanotechnology Revenue Market Share by Application
4 Global Healthcare Nanotechnology by Company
4.1 Global Healthcare Nanotechnology Revenue by Company (2020-2025)
4.2 Global Healthcare Nanotechnology Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Healthcare Nanotechnology Companies around the World: Ranking by Revenue
4.3.2 Global Healthcare Nanotechnology Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Healthcare Nanotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Healthcare Nanotechnology Companies Headquarters & Product Type
4.4.1 Global Healthcare Nanotechnology Companies Headquarters
4.4.2 Date of International Companies Enter into Healthcare Nanotechnology Market
4.4.3 Global Healthcare Nanotechnology Companies Product & Service
4.4.4 Nanomedicine Revenue Market Share of Healthcare Nanotechnology by Company
4.4.5 Nano Medical Devices Revenue Market Share of Healthcare Nanotechnology by Company
4.4.6 Nano Diagnosis Revenue Market Share of Healthcare Nanotechnology by Company
4.4.7 Others Revenue Market Share of Healthcare Nanotechnology by Company
4.5 Global Healthcare Nanotechnology Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Amgen
5.1.1 Amgen Corporation Information
5.1.2 Amgen Description, Business Overview
5.1.3 Amgen Healthcare Nanotechnology Products Offered
5.1.4 Amgen Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.1.5 Amgen Healthcare Nanotechnology Revenue by Product in 2024
5.1.6 Amgen Healthcare Nanotechnology Revenue by Application in 2024
5.1.7 Amgen Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.1.8 Amgen Recent Developments
5.2 Teva Pharmaceuticals
5.2.1 Teva Pharmaceuticals Corporation Information
5.2.2 Teva Pharmaceuticals Description, Business Overview
5.2.3 Teva Pharmaceuticals Healthcare Nanotechnology Products Offered
5.2.4 Teva Pharmaceuticals Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.2.5 Teva Pharmaceuticals Healthcare Nanotechnology Revenue by Product in 2024
5.2.6 Teva Pharmaceuticals Healthcare Nanotechnology Revenue by Application in 2024
5.2.7 Teva Pharmaceuticals Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.2.8 Teva Pharmaceuticals Recent Developments
5.3 Abbott
5.3.1 Abbott Corporation Information
5.3.2 Abbott Description, Business Overview
5.3.3 Abbott Healthcare Nanotechnology Products Offered
5.3.4 Abbott Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.3.5 Abbott Healthcare Nanotechnology Revenue by Product in 2024
5.3.6 Abbott Healthcare Nanotechnology Revenue by Application in 2024
5.3.7 Abbott Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.3.8 Abbott Recent Developments
5.4 UCB
5.4.1 UCB Corporation Information
5.4.2 UCB Description, Business Overview
5.4.3 UCB Healthcare Nanotechnology Products Offered
5.4.4 UCB Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.4.5 UCB Healthcare Nanotechnology Revenue by Product in 2024
5.4.6 UCB Healthcare Nanotechnology Revenue by Application in 2024
5.4.7 UCB Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.4.8 UCB Recent Developments
5.5 Roche
5.5.1 Roche Corporation Information
5.5.2 Roche Description, Business Overview
5.5.3 Roche Healthcare Nanotechnology Products Offered
5.5.4 Roche Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.5.5 Roche Healthcare Nanotechnology Revenue by Product in 2024
5.5.6 Roche Healthcare Nanotechnology Revenue by Application in 2024
5.5.7 Roche Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.5.8 Roche Recent Developments
5.6 Celgene
5.6.1 Celgene Corporation Information
5.6.2 Celgene Description, Business Overview
5.6.3 Celgene Healthcare Nanotechnology Products Offered
5.6.4 Celgene Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.6.5 Celgene Healthcare Nanotechnology Revenue by Product in 2024
5.6.6 Celgene Healthcare Nanotechnology Revenue by Application in 2024
5.6.7 Celgene Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.6.8 Celgene Recent Developments
5.7 Sanofi
5.7.1 Sanofi Corporation Information
5.7.2 Sanofi Description, Business Overview
5.7.3 Sanofi Healthcare Nanotechnology Products Offered
5.7.4 Sanofi Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.7.5 Sanofi Healthcare Nanotechnology Revenue by Product in 2024
5.7.6 Sanofi Healthcare Nanotechnology Revenue by Application in 2024
5.7.7 Sanofi Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.7.8 Sanofi Recent Developments
5.8 Merck & Co
5.8.1 Merck & Co Corporation Information
5.8.2 Merck & Co Description, Business Overview
5.8.3 Merck & Co Healthcare Nanotechnology Products Offered
5.8.4 Merck & Co Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.8.5 Merck & Co Healthcare Nanotechnology Revenue by Product in 2024
5.8.6 Merck & Co Healthcare Nanotechnology Revenue by Application in 2024
5.8.7 Merck & Co Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.8.8 Merck & Co Recent Developments
5.9 Biogen
5.9.1 Biogen Corporation Information
5.9.2 Biogen Description, Business Overview
5.9.3 Biogen Healthcare Nanotechnology Products Offered
5.9.4 Biogen Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.9.5 Biogen Healthcare Nanotechnology Revenue by Product in 2024
5.9.6 Biogen Healthcare Nanotechnology Revenue by Application in 2024
5.9.7 Biogen Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.9.8 Biogen Recent Developments
5.10 Stryker
5.10.1 Stryker Corporation Information
5.10.2 Stryker Description, Business Overview
5.10.3 Stryker Healthcare Nanotechnology Products Offered
5.10.4 Stryker Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.10.5 Stryker Healthcare Nanotechnology Revenue by Product in 2024
5.10.6 Stryker Healthcare Nanotechnology Revenue by Application in 2024
5.10.7 Stryker Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.10.8 Stryker Recent Developments
5.11 Gilead Sciences
5.11.1 Gilead Sciences Corporation Information
5.11.2 Gilead Sciences Description, Business Overview
5.11.3 Gilead Sciences Healthcare Nanotechnology Products Offered
5.11.4 Gilead Sciences Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.11.5 Gilead Sciences Healthcare Nanotechnology Revenue by Product in 2024
5.11.6 Gilead Sciences Healthcare Nanotechnology Revenue by Application in 2024
5.11.7 Gilead Sciences Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.11.8 Gilead Sciences Recent Developments
5.12 Pfizer
5.12.1 Pfizer Corporation Information
5.12.2 Pfizer Description, Business Overview
5.12.3 Pfizer Healthcare Nanotechnology Products Offered
5.12.4 Pfizer Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.12.5 Pfizer Healthcare Nanotechnology Revenue by Product in 2024
5.12.6 Pfizer Healthcare Nanotechnology Revenue by Application in 2024
5.12.7 Pfizer Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.12.8 Pfizer Recent Developments
5.13 3M Company
5.13.1 3M Company Corporation Information
5.13.2 3M Company Description, Business Overview
5.13.3 3M Company Healthcare Nanotechnology Products Offered
5.13.4 3M Company Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.13.5 3M Company Healthcare Nanotechnology Revenue by Product in 2024
5.13.6 3M Company Healthcare Nanotechnology Revenue by Application in 2024
5.13.7 3M Company Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.13.8 3M Company Recent Developments
5.14 Johnson & Johnson
5.14.1 Johnson & Johnson Corporation Information
5.14.2 Johnson & Johnson Description, Business Overview
5.14.3 Johnson & Johnson Healthcare Nanotechnology Products Offered
5.14.4 Johnson & Johnson Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.14.5 Johnson & Johnson Healthcare Nanotechnology Revenue by Product in 2024
5.14.6 Johnson & Johnson Healthcare Nanotechnology Revenue by Application in 2024
5.14.7 Johnson & Johnson Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.14.8 Johnson & Johnson Recent Developments
5.15 Smith & Nephew
5.15.1 Smith & Nephew Corporation Information
5.15.2 Smith & Nephew Description, Business Overview
5.15.3 Smith & Nephew Healthcare Nanotechnology Products Offered
5.15.4 Smith & Nephew Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.15.5 Smith & Nephew Healthcare Nanotechnology Revenue by Product in 2024
5.15.6 Smith & Nephew Healthcare Nanotechnology Revenue by Application in 2024
5.15.7 Smith & Nephew Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.15.8 Smith & Nephew Recent Developments
5.16 Leadiant Biosciences
5.16.1 Leadiant Biosciences Corporation Information
5.16.2 Leadiant Biosciences Description, Business Overview
5.16.3 Leadiant Biosciences Healthcare Nanotechnology Products Offered
5.16.4 Leadiant Biosciences Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.16.5 Leadiant Biosciences Healthcare Nanotechnology Revenue by Product in 2024
5.16.6 Leadiant Biosciences Healthcare Nanotechnology Revenue by Application in 2024
5.16.7 Leadiant Biosciences Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.16.8 Leadiant Biosciences Recent Developments
5.17 Kyowa Hakko Kirin
5.17.1 Kyowa Hakko Kirin Corporation Information
5.17.2 Kyowa Hakko Kirin Description, Business Overview
5.17.3 Kyowa Hakko Kirin Healthcare Nanotechnology Products Offered
5.17.4 Kyowa Hakko Kirin Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.17.5 Kyowa Hakko Kirin Healthcare Nanotechnology Revenue by Product in 2024
5.17.6 Kyowa Hakko Kirin Healthcare Nanotechnology Revenue by Application in 2024
5.17.7 Kyowa Hakko Kirin Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.17.8 Kyowa Hakko Kirin Recent Developments
5.18 Shire
5.18.1 Shire Corporation Information
5.18.2 Shire Description, Business Overview
5.18.3 Shire Healthcare Nanotechnology Products Offered
5.18.4 Shire Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.18.5 Shire Healthcare Nanotechnology Revenue by Product in 2024
5.18.6 Shire Healthcare Nanotechnology Revenue by Application in 2024
5.18.7 Shire Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.18.8 Shire Recent Developments
5.19 Ipsen
5.19.1 Ipsen Corporation Information
5.19.2 Ipsen Description, Business Overview
5.19.3 Ipsen Healthcare Nanotechnology Products Offered
5.19.4 Ipsen Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.19.5 Ipsen Healthcare Nanotechnology Revenue by Product in 2024
5.19.6 Ipsen Healthcare Nanotechnology Revenue by Application in 2024
5.19.7 Ipsen Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.19.8 Ipsen Recent Developments
5.20 Endo International
5.20.1 Endo International Corporation Information
5.20.2 Endo International Description, Business Overview
5.20.3 Endo International Healthcare Nanotechnology Products Offered
5.20.4 Endo International Healthcare Nanotechnology Revenue and Gross Margin (2020-2025)
5.20.5 Endo International Healthcare Nanotechnology Revenue by Product in 2024
5.20.6 Endo International Healthcare Nanotechnology Revenue by Application in 2024
5.20.7 Endo International Healthcare Nanotechnology Revenue by Geographic Area in 2024
5.20.8 Endo International Recent Developments
6 North America
6.1 North America Healthcare Nanotechnology Market Size YoY Growth 2020-2031
6.2 North America Healthcare Nanotechnology Market Facts & Figures by Country (2020-2031)
6.3 North America Healthcare Nanotechnology Revenue by Type (2020-2025)
6.4 North America Healthcare Nanotechnology Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Healthcare Nanotechnology Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Healthcare Nanotechnology Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Healthcare Nanotechnology Revenue by Type (2020-2025)
7.4 Asia-Pacific Healthcare Nanotechnology Revenue by Application (2020-2025)
8 Europe
8.1 Europe Healthcare Nanotechnology Market Size YoY Growth 2020-2031
8.2 Europe Healthcare Nanotechnology Market Facts & Figures by Country (2020-2031)
8.3 Europe Healthcare Nanotechnology Revenue by Type (2020-2025)
8.4 Europe Healthcare Nanotechnology Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Healthcare Nanotechnology Market Size YoY Growth 2020-2031
9.2 Latin America Healthcare Nanotechnology Market Facts & Figures by Country (2020-2031)
9.3 Latin America Healthcare Nanotechnology Revenue by Type (2020-2025)
9.4 Latin America Healthcare Nanotechnology Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Healthcare Nanotechnology Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Healthcare Nanotechnology Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Healthcare Nanotechnology Revenue by Type (2020-2025)
10.4 Middle East and Africa Healthcare Nanotechnology Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Healthcare Nanotechnology Supply Chain Analysis
11.2 Healthcare Nanotechnology Key Raw Materials and Upstream Suppliers
11.3 Healthcare Nanotechnology Clients Analysis
11.4 Healthcare Nanotechnology Sales Channel and Sales Model Analysis
11.4.1 Healthcare Nanotechnology Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Healthcare Nanotechnology Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Healthcare Nanotechnology Distributors
12 Healthcare Nanotechnology Market Dynamics
12.1 Healthcare Nanotechnology Industry Trends
12.2 Healthcare Nanotechnology Market Drivers
12.3 Healthcare Nanotechnology Market Challenges
12.4 Healthcare Nanotechnology Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Healthcare Nanotechnology Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Healthcare Nanotechnology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Healthcare Nanotechnology Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Healthcare Nanotechnology Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Healthcare Nanotechnology Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Healthcare Nanotechnology Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Healthcare Nanotechnology Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Healthcare Nanotechnology Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Healthcare Nanotechnology Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Healthcare Nanotechnology Revenue by Company (2020-2025) & (US$ Million)
Table 11. Healthcare Nanotechnology Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Healthcare Nanotechnology Players by Revenue (US$ Million) in 2024
Table 13. Global Healthcare Nanotechnology Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Healthcare Nanotechnology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare Nanotechnology as of 2024)
Table 15. Global Healthcare Nanotechnology Companies Headquarters
Table 16. Date of International Companies Enter into Healthcare Nanotechnology Market
Table 17. Global Healthcare Nanotechnology Companies Product & Service
Table 18. Global Healthcare Nanotechnology Mergers & Acquisitions, Expansion Plans
Table 19. Amgen Corporation Information
Table 20. Amgen Description and Business Overview
Table 21. Amgen Healthcare Nanotechnology Product
Table 22. Amgen Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Amgen Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 24. Amgen Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 25. Amgen Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 26. Amgen Recent Developments
Table 27. Teva Pharmaceuticals Corporation Information
Table 28. Teva Pharmaceuticals Description and Business Overview
Table 29. Teva Pharmaceuticals Healthcare Nanotechnology Product
Table 30. Teva Pharmaceuticals Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Teva Pharmaceuticals Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 32. Teva Pharmaceuticals Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 33. Teva Pharmaceuticals Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 34. Teva Pharmaceuticals Recent Developments
Table 35. Abbott Corporation Information
Table 36. Abbott Description and Business Overview
Table 37. Abbott Healthcare Nanotechnology Product
Table 38. Abbott Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Abbott Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 40. Abbott Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 41. Abbott Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 42. Abbott Recent Developments
Table 43. UCB Corporation Information
Table 44. UCB Description and Business Overview
Table 45. UCB Healthcare Nanotechnology Product
Table 46. UCB Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. UCB Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 48. UCB Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 49. UCB Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 50. UCB Recent Developments
Table 51. Roche Corporation Information
Table 52. Roche Description and Business Overview
Table 53. Roche Healthcare Nanotechnology Product
Table 54. Roche Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Roche Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 56. Roche Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 57. Roche Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 58. Roche Recent Developments
Table 59. Celgene Corporation Information
Table 60. Celgene Description and Business Overview
Table 61. Celgene Healthcare Nanotechnology Product
Table 62. Celgene Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Celgene Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 64. Celgene Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 65. Celgene Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 66. Celgene Recent Developments
Table 67. Sanofi Corporation Information
Table 68. Sanofi Description and Business Overview
Table 69. Sanofi Healthcare Nanotechnology Product
Table 70. Sanofi Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Sanofi Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 72. Sanofi Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 73. Sanofi Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 74. Sanofi Recent Developments
Table 75. Merck & Co Corporation Information
Table 76. Merck & Co Description and Business Overview
Table 77. Merck & Co Healthcare Nanotechnology Product
Table 78. Merck & Co Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Merck & Co Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 80. Merck & Co Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 81. Merck & Co Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 82. Merck & Co Recent Developments
Table 83. Biogen Corporation Information
Table 84. Biogen Description and Business Overview
Table 85. Biogen Healthcare Nanotechnology Product
Table 86. Biogen Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Biogen Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 88. Biogen Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 89. Biogen Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 90. Biogen Recent Developments
Table 91. Stryker Corporation Information
Table 92. Stryker Description and Business Overview
Table 93. Stryker Healthcare Nanotechnology Product
Table 94. Stryker Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Stryker Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 96. Stryker Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 97. Stryker Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 98. Stryker Recent Developments
Table 99. Gilead Sciences Corporation Information
Table 100. Gilead Sciences Description and Business Overview
Table 101. Gilead Sciences Healthcare Nanotechnology Product
Table 102. Gilead Sciences Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Gilead Sciences Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 104. Gilead Sciences Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 105. Gilead Sciences Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 106. Gilead Sciences Recent Developments
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Business Overview
Table 109. Pfizer Healthcare Nanotechnology Product
Table 110. Pfizer Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Pfizer Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 112. Pfizer Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 113. Pfizer Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 114. Pfizer Recent Developments
Table 115. 3M Company Corporation Information
Table 116. 3M Company Description and Business Overview
Table 117. 3M Company Healthcare Nanotechnology Product
Table 118. 3M Company Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. 3M Company Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 120. 3M Company Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 121. 3M Company Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 122. 3M Company Recent Developments
Table 123. Johnson & Johnson Corporation Information
Table 124. Johnson & Johnson Description and Business Overview
Table 125. Johnson & Johnson Healthcare Nanotechnology Product
Table 126. Johnson & Johnson Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Johnson & Johnson Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 128. Johnson & Johnson Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 129. Johnson & Johnson Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 130. Johnson & Johnson Recent Developments
Table 131. Smith & Nephew Corporation Information
Table 132. Smith & Nephew Description and Business Overview
Table 133. Smith & Nephew Healthcare Nanotechnology Product
Table 134. Smith & Nephew Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Smith & Nephew Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 136. Smith & Nephew Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 137. Smith & Nephew Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 138. Smith & Nephew Recent Developments
Table 139. Leadiant Biosciences Corporation Information
Table 140. Leadiant Biosciences Description and Business Overview
Table 141. Leadiant Biosciences Healthcare Nanotechnology Product
Table 142. Leadiant Biosciences Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Leadiant Biosciences Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 144. Leadiant Biosciences Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 145. Leadiant Biosciences Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 146. Leadiant Biosciences Recent Developments
Table 147. Kyowa Hakko Kirin Corporation Information
Table 148. Kyowa Hakko Kirin Description and Business Overview
Table 149. Kyowa Hakko Kirin Healthcare Nanotechnology Product
Table 150. Kyowa Hakko Kirin Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Kyowa Hakko Kirin Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 152. Kyowa Hakko Kirin Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 153. Kyowa Hakko Kirin Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 154. Kyowa Hakko Kirin Recent Developments
Table 155. Shire Corporation Information
Table 156. Shire Description and Business Overview
Table 157. Shire Healthcare Nanotechnology Product
Table 158. Shire Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Shire Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 160. Shire Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 161. Shire Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 162. Shire Recent Developments
Table 163. Ipsen Corporation Information
Table 164. Ipsen Description and Business Overview
Table 165. Ipsen Healthcare Nanotechnology Product
Table 166. Ipsen Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. Ipsen Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 168. Ipsen Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 169. Ipsen Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 170. Ipsen Recent Developments
Table 171. Endo International Corporation Information
Table 172. Endo International Description and Business Overview
Table 173. Endo International Healthcare Nanotechnology Product
Table 174. Endo International Healthcare Nanotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 175. Endo International Revenue Proportion of Healthcare Nanotechnology by Product in 2024
Table 176. Endo International Revenue Proportion of Healthcare Nanotechnology by Application in 2024
Table 177. Endo International Revenue Proportion of Healthcare Nanotechnology by Geographic Area in 2024
Table 178. Endo International Recent Developments
Table 179. North America Healthcare Nanotechnology Revenue by Country (2020-2025) & (US$ Million)
Table 180. North America Healthcare Nanotechnology Revenue by Country (2026-2031) & (US$ Million)
Table 181. North America Healthcare Nanotechnology Revenue by Type (2020-2025) & (US$ Million)
Table 182. North America Healthcare Nanotechnology Revenue by Application (2020-2025) & (US$ Million)
Table 183. Asia-Pacific Healthcare Nanotechnology Revenue by Region (2020-2025) & (US$ Million)
Table 184. Asia-Pacific Healthcare Nanotechnology Revenue by Region (2026-2031) & (US$ Million)
Table 185. Asia-Pacific Healthcare Nanotechnology Revenue by Type (2020-2025) & (US$ Million)
Table 186. Asia-Pacific Healthcare Nanotechnology Revenue by Application (2020-2025) & (US$ Million)
Table 187. Europe Healthcare Nanotechnology Revenue by Country (2020-2025) & (US$ Million)
Table 188. Europe Healthcare Nanotechnology Revenue by Country (2026-2031) & (US$ Million)
Table 189. Europe Healthcare Nanotechnology Revenue by Type (2020-2025) & (US$ Million)
Table 190. Europe Healthcare Nanotechnology Revenue by Application (2020-2025) & (US$ Million)
Table 191. Latin America Healthcare Nanotechnology Revenue by Country (2020-2025) & (US$ Million)
Table 192. Latin America Healthcare Nanotechnology Revenue by Country (2026-2031) & (US$ Million)
Table 193. Latin America Healthcare Nanotechnology Revenue by Type (2020-2025) & (US$ Million)
Table 194. Latin America Healthcare Nanotechnology Revenue by Application (2020-2025) & (US$ Million)
Table 195. Middle East and Africa Healthcare Nanotechnology Revenue by Country (2020-2025) & (US$ Million)
Table 196. Middle East and Africa Healthcare Nanotechnology Revenue by Country (2026-2031) & (US$ Million)
Table 197. Middle East and Africa Healthcare Nanotechnology Revenue by Type (2020-2025) & (US$ Million)
Table 198. Middle East and Africa Healthcare Nanotechnology Revenue by Application (2020-2025) & (US$ Million)
Table 199. Healthcare Nanotechnology Key Raw Materials, Industry Status and Trend
Table 200. Healthcare Nanotechnology Key Raw Materials and Upstream Suppliers
Table 201. Healthcare Nanotechnology Clients Status and Trend
Table 202. Healthcare Nanotechnology Typical Clients
Table 203. Healthcare Nanotechnology Distributors
Table 204. Healthcare Nanotechnology Market Trends
Table 205. Healthcare Nanotechnology Market Drivers
Table 206. Healthcare Nanotechnology Market Challenges
Table 207. Healthcare Nanotechnology Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Healthcare Nanotechnology Product Picture
Figure 2. Global Healthcare Nanotechnology Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Healthcare Nanotechnology Revenue Market Share by Type in 2024 & 2031
Figure 4. Nanomedicine Product Picture
Figure 5. Nano Medical Devices Product Picture
Figure 6. Nano Diagnosis Product Picture
Figure 7. Others Product Picture
Figure 8. Global Healthcare Nanotechnology Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Healthcare Nanotechnology Revenue Market Share by Application in 2024 & 2031
Figure 10. Anticancer
Figure 11. CNS Product
Figure 12. Anti-infective
Figure 13. Others
Figure 14. Healthcare Nanotechnology Report Years Considered
Figure 15. Global Healthcare Nanotechnology Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Healthcare Nanotechnology Market Size (2020-2031) & (US$ Million)
Figure 17. Global Healthcare Nanotechnology Market Size Market Share by Region: 2024 Versus 2031
Figure 18. Global Healthcare Nanotechnology Revenue Market Share by Region (2020-2031)
Figure 19. Global Healthcare Nanotechnology Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Global Healthcare Nanotechnology Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Nanomedicine of Healthcare Nanotechnology Revenue Market Share by Application, 2024 VS 2031
Figure 22. Nano Medical Devices of Healthcare Nanotechnology Revenue Market Share by Application, 2024 VS 2031
Figure 23. Nano Diagnosis of Healthcare Nanotechnology Revenue Market Share by Application, 2024 VS 2031
Figure 24. Others of Healthcare Nanotechnology Revenue Market Share by Application, 2024 VS 2031
Figure 25. Healthcare Nanotechnology Revenue Share by Company (2024)
Figure 26. Healthcare Nanotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Nanomedicine Revenue Proportion by Company in 2024
Figure 28. Nano Medical Devices Revenue Proportion by Company in 2024
Figure 29. Nano Diagnosis Revenue Proportion by Company in 2024
Figure 30. Others Revenue Proportion by Company in 2024
Figure 31. North America Healthcare Nanotechnology Revenue 2020-2031 (US$ Million)
Figure 32. North America Healthcare Nanotechnology Revenue Market Share by Type (2020-2025)
Figure 33. North America Healthcare Nanotechnology Revenue Market Share by Application (2020-2025)
Figure 34. Asia-Pacific Healthcare Nanotechnology Revenue 2020-2031 (US$ Million)
Figure 35. Asia-Pacific Healthcare Nanotechnology Revenue Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Healthcare Nanotechnology Revenue Market Share by Type (2020-2025)
Figure 37. Asia-Pacific Healthcare Nanotechnology Revenue Market Share by Application (2020-2025)
Figure 38. Europe Healthcare Nanotechnology Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Europe Healthcare Nanotechnology Revenue Market Share by Country (2020-2031)
Figure 40. Europe Healthcare Nanotechnology Revenue Market Share by Type (2020-2025)
Figure 41. Europe Healthcare Nanotechnology Revenue Market Share by Application (2020-2025)
Figure 42. Latin America Healthcare Nanotechnology Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Healthcare Nanotechnology Revenue Market Share by Country (2020-2031)
Figure 44. Latin America Healthcare Nanotechnology Revenue Market Share by Type (2020-2025)
Figure 45. Latin America Healthcare Nanotechnology Revenue Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Healthcare Nanotechnology Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Healthcare Nanotechnology Revenue Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Healthcare Nanotechnology Revenue Market Share by Type (2020-2025)
Figure 49. Middle East and Africa Healthcare Nanotechnology Revenue Market Share by Application (2020-2025)
Figure 50. Healthcare Nanotechnology Supply Chain (Upstream and Downstream Market)
Figure 51. Global Production Market Share of Healthcare Nanotechnology Raw Materials by Region in 2024
Figure 52. Healthcare Nanotechnology Distribution Channels
Figure 53. Global Healthcare Nanotechnology Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 54. Global Healthcare Nanotechnology Percentage 2020-2031: Online Sales VS Offline Sales
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
